Apollo <APO.N>: BMO Cuts Target Price to $126 From $140
APO•Related News
Tactile Medical signs exclusive VA, DoD distribution deal with ElastiMed for MyoSleeve device
TCMD•
Lumentum sets fiscal 2026 fourth-quarter and full-year results webcast
LITE•
Alarum appoints external cyber forensics team to probe NetNut proxy network disruption
ALAR•
Madrigal wins three new US patents for MASH drug Rezdiffra, boosting IP protection
MDGL•
Clearmind Medicine posts update on CMND-100 first-in-human trial webinar insights
CMND•